SCHEMBL7562030

SCHEMBL7562030

C=C(C)CC(NC=O)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRN P28799 1/20 0.44
SORT1 Q99523 1/20 0.44
TGFBR1 P36897 1/20 0.40
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
ALOX15 P16050 1/20 0.35
NFKB1 P19838 1/20 0.35
PTGS2 P35354 1/20 0.35
THPO P40225 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 1/20 0.34
CTSL P07711 1/20 0.32
ADH1B P00325 1/20 0.31
ADH1C P00326 1/20 0.31
ADH1A P07327 1/20 0.31
FOLH1 Q04609 2/20 0.31
NAALAD2 Q9Y3Q0 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28337307 0.83 KDM4E (0.38) TGFBR1KDM4EMAPTTHRBALOX15
SCHEMBL8337750 0.79 CA2 (0.42) MAPTSMN1; SMN2FOLH1NAALAD2
SCHEMBL6746101 0.79 CA2 (0.42) MAPTSMN1; SMN2FOLH1NAALAD2
SCHEMBL805252 0.77 GRN (0.47) GRNSORT1TGFBR1KDM4EMAPT
SCHEMBL27952437 0.76 TGFBR1 (0.36) TGFBR1KDM4EMAPTTHRBALOX15
SCHEMBL15444859 0.76 TGFBR1 (0.32) TGFBR1ADH1BADH1CADH1A
SCHEMBL8028150 0.75 ECE1 (0.42) TGFBR1KDM4EMAPTALDH1A1FOLH1
SCHEMBL2918805 0.75 ECE1 (0.42) TGFBR1KDM4EMAPTALDH1A1FOLH1
SCHEMBL9810229 0.74 GRIK1 (0.44)
SCHEMBL29956040 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1194443-A1 CYSTEINYL PROTEASE INHIBITORS Merck & Co., Inc. (US) 2002-04-10 EP disclosed
WO-2000078794-A1 CYSTEINYL PROTEASE INHIBITORS MERCK & CO., INC. (US) 2000-12-28 WO disclosed